Swedish biotech company Melt&Marble has raised €7.3 million in Series A funding to scale the production of its designer fats made using precision fermentation and bring its first ingredients to market.
The round was led by Swedish deeptech investor Industrifonden, with participation from the European Commission’s European Innovation Council (EIC) Fund, Beiersdorf, Valio, Chalmers Ventures, and Catalyze Capital. The EIC Accelerator previously awarded Melt&Marble a €2.5 million grant in 2024, while the Horizon Europe Framework Programme provided an additional €260,000. This brings the total funding raised by the company over the past year to around €10 million.
Melt&Marble’s ingredients provide sustainable, high performance alternatives to conventional oils and fats for applications such as personal care, beauty, meat and dairy alternatives, chocolate confectionery, bakery products, and specialised nutrition. The fats are designed to deliver enhanced functionality, taste, and health outcomes. In comparison, traditional products like palm oil, coconut oil, and animal-based fats are said to struggle with performance, supply volatility, and environmental criteria.
The new funding will reportedly take Melt&Marble from demo to market-ready; the company’s first ingredients are set for commercial launch in personal care applications next year. Production will take place through an existing commercial manufacturing partner, ensuring capex-light scalability.
“The capabilities to deliver real impact”
Melt&Marble’s precision fermentation platform provides animal-free, tailored fat structures that are claimed to offer superior functionality, from improved texture and mouthfeel in food to enhanced skin-feel and bio-activity in cosmetics. By engineering fats from the molecule up, the company says it can deliver cost-competitive, locally produced ingredients that meet technical demands and sustainability goals.
The new raise comes as Melt&Marble explores opportunities with industry players across multiple regions, after achieving strong application results and major advances in bioprocess efficiency. The company is initially focusing on the European market, but is also preparing to enter the US food market, where regulatory pathways should allow for faster deployment. Additionally, Melt&Marble is considering other geographies for further expansion.
Commercial collaboration and distribution discussions are already underway, and Melt&Marble is currently working on co-development products with partners in preparation for its commercial launch.
“This investment marks a major milestone for Melt&Marble, as we transition from R&D to commercialisation,” said Anastasia Krivoruchko, CEO of
Melt&Marble. “With key scalability milestones already achieved and strategic partners onboard, we’re entering the market with the capabilities and confidence to deliver real impact. Our vision has always been to deliver more sustainable, high-performance ingredients, and this round brings us significantly closer to that goal.”
